Preoperative Haematologic Markers for the Differentiation of Endometrial Cancer from Benign Endometrial Lesions in Postmenopausal Patients with Endometrial Masses

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.21654
   PubMed Web of Science ®Google Scholar
• Hong S, Won YJ, Lee JJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2018. Cancer Res Treat. 2021;53(2):301–315. doi:10.4143/crt.2021.291
   PubMed Web of Science ®Google Scholar
• Ha HI, Chang HK, Park SJ, Lim JW, Won YJ, Lim MC. The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999–2017: Korea Central Cancer Registry. Obstet Gynecol Sci. 2021;64(5):444–453. doi:10.5468/ogs.21116
   PubMedGoogle Scholar
• Dreisler E, Sorensen SS, Ibsen PH, Lose G. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20–74 years. Ultrasound Obstet Gynecol. 2009;33(1):102–108. doi:10.1002/uog.6259
   PubMed Web of Science ®Google Scholar
• Uglietti A, Buggio L, Farella M, et al. The risk of malignancy in uterine polyps: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2019;237:48–56. doi:10.1016/j.ejogrb.2019.04.009
   PubMed Web of Science ®Google Scholar
• Bel S, Billard C, Godet J, et al. Risk of malignancy on suspicion of polyps in menopausal women. Eur J Obstet Gynecol Reprod Biol. 2017;216:138–142. doi:10.1016/j.ejogrb.2017.07.013
   PubMed Web of Science ®Google Scholar
• Xia Z, Jin H, Teekaraman Y. Diagnostic value of ultrasonography combined with hysteroscopy in intrauterine space-occupying abnormalities. Contrast Media Mol Imaging. 2022;2022:6192311. doi:10.1155/2022/6192311
   PubMed Web of Science ®Google Scholar
• Moharamzad Y, Davarpanah AH, Yaghobi Joybari A, et al. Diagnostic performance of apparent diffusion coefficient (ADC) for differentiating endometrial carcinoma from benign lesions: a systematic review and meta-analysis. Abdom Radiol. 2021;46(3):1115–1128. doi:10.1007/s00261-020-02734-w
   PubMed Web of Science ®Google Scholar
• Kierans AS, Bennett GL, Haghighi M, Rosenkrantz AB. Utility of conventional and diffusion-weighted MRI features in distinguishing benign from malignant endometrial lesions. Eur J Radiol. 2014;83(4):726–732. doi:10.1016/j.ejrad.2013.11.030
   PubMed Web of Science ®Google Scholar
• Wong M, Thanatsis N, Nardelli F, Amin T, Jurkovic D. Risk of pre-malignancy or malignancy in postmenopausal endometrial polyps: a CHAID decision tree analysis. Diagnostics. 2021;11(6):1094. doi:10.3390/diagnostics11061094
   Web of Science ®Google Scholar
• Vural F, Coşkun ADE, Çıtak G, Vural B, Köse G. The comparison of inflammatory markers in geriatric and nongeriatric endometrial cancers. Cancer Biomark. 2022;34(4):583–590. doi:10.3233/CBM-210215
   PubMed Web of Science ®Google Scholar
• Suh DS, Song YJ, Roh HJ, et al. Preoperative blood inflammatory markers for the differentiation of uterine leiomyosarcoma from leiomyoma. Cancer Manag Res. 2021;13:5001–5011. doi:10.2147/CMAR.S314219
   PubMed Web of Science ®Google Scholar
• Eo WK, Kim KH, Park EJ, et al. Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian masses. J Cancer. 2018;9(7):1165. doi:10.7150/jca.23606
   PubMed Web of Science ®Google Scholar
• Wu Q, Bai SN, Song LY, Wu WF, Han LN. Diagnostic value of serum human epididymis protein 4, carbohydrate antigen 125 and their combination in endometrial cancer: a meta-analysis. Medicine. 2023;102(33):e34737. doi:10.1097/MD.0000000000034737
   PubMed Web of Science ®Google Scholar
• Zhang H, Liang K, Ke L, Tang S. Clinical application of red cell distribution width, mean platelet volume, and cancer antigen 125 detection in endometrial cancer. Clin Lab Anal. 2020;34(8):e23309. doi:10.1002/jcla.23309
   PubMed Web of Science ®Google Scholar
• Sadro CT. Imaging the endometrium: a pictorial essay. Can Assoc Radiol J. 2016;67(3):254–262. doi:10.1016/j.carj.2015.09.012
   PubMed Web of Science ®Google Scholar
• Kurtoglu E, Kokcu A, Celik H, Sari S, Tosun M. Platelet indices may be useful in discrimination of benign and malign endometrial lesions, and early and advanced stage endometrial cancer. Asian Pac J Cancer Prev. 2015;16(13):5397‐5400. doi:10.7314/APJCP.2015.16.13.5397
   Google Scholar
• Acmaz G, Aksoy H, Unal D, et al. Are neutrophil/ lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding. Asian Pac J Cancer Prev. 2014;15(4):1689–1692. doi:10.7314/APJCP.2014.15.4.1689
   PubMedGoogle Scholar
• Karateke KM, Baloglu A, Baloglu A. Relations of platelet indices with endometrial hyperplasia and endometrial cancer. Asian Pac J Cancer Prev. 2015;16(12):4905–4908. doi:10.7314/APJCP.2015.16.12.4905
   PubMedGoogle Scholar
• Kemal Y, Demirag G, Baş B, Önem S, Teker F, Yücel İ. The value of red blood cell distribution width in endometrial cancer. Clin Chem Lab Med. 2015;53(5):823–827. doi:10.1515/cclm-2014-0699
   PubMed Web of Science ®Google Scholar
• Ural ÜM, Şehitoğlu İ, Tekin YB, Şahin FK. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in patients with endometrial hyperplasia and endometrial cancer. J Obstet Gynaecol Res. 2015;41(3):445–448. doi:10.1111/jog.12536
   PubMed Web of Science ®Google Scholar
• Abide CY, Bostanci EE, Cogendez E, et al. Evaluation of complete blood count parameters to predict endometrial cancer. Clin Lab Anal. 2018;32(6):e22438. doi:10.1002/jcla.22438
   PubMed Web of Science ®Google Scholar
• Pergialiotis V, Oikonomou M, Damaskou V, Kalantzis D, Chrelias C, Tsantes AE. Platelet to lymphocyte and neutrophil to lymphocyte ratio as predictive indices of endometrial carcinoma: findings from a retrospective series of patients and meta-analysis. J Gynecol Obstet Hum Reprod. 2018;47(10):511–516. doi:10.1016/j.jogoh.2018.08.016
   PubMed Web of Science ®Google Scholar
• Bacanakgil BH, Kaban I, Unal F, Guven R, Sahin E, Yildirim SG. Predictive Value of Hematological Inflammatory Markers in Endometrial Neoplasia. Asian Pac J Cancer Prev. 2018;19(6):1529–1532. doi:10.22034/APJCP.2018.19.6.1529
   PubMedGoogle Scholar
• Alper ECD, Coşkun ADE, Vural F. Comparison of nonspecific inflammatory markers in endometrial cancer and hyperplasia. Rev Assoc Med Bras. 2021;67(7):966–970. doi:10.1590/1806-9282.20210318
   PubMed Web of Science ®Google Scholar
• Ilgen O, Kurt S, Yuzuguldu R, Ada O, Mankan A. Platelet to lymphocyte and neutrophil to lymphocyte ratios in endometrial pathologies. Ginekol Pol. 2023;94(4):269–274. doi:10.5603/GP.a2021.0141
   PubMed Web of Science ®Google Scholar
• Valiathan R, Ashman M, Asthana D. Effects of ageing on the immune system: infants to elderly. Scand J Immunol. 2016;83(4):255–266. doi:10.1111/sji.12413
   PubMed Web of Science ®Google Scholar
• Kaya S, Kaya B, Keskin HL, Tetik BK, Yavuz FA. Is there any relationship between benign endometrial pathologies and metabolic status? J Obstet Gynaecol. 2019;39(2):176–183. doi:10.1080/01443615.2018.1469606
   PubMedGoogle Scholar
• Knific T, Osredkar J, Smrkolj Š, et al. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer. Gynecol Oncol. 2017;147(1):126–132. doi:10.1016/j.ygyno.2017.07.130
   PubMed Web of Science ®Google Scholar
• Kim BW, Jeon YE, Cho HB, et al. Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte. J Obstet Gynaecol Res. 2012;38(1):48–56. doi:10.1111/j.1447-0756.2011.01694.x
   PubMed Web of Science ®Google Scholar
• Abdalla N, Pazura M, Słomka A, Piórkowski R, Sawicki W, Cendrowski K. The role of HE4 and CA125 in differentiation between malignant and non-malignant endometrial pathologies. Ginekol Pol. 2016;87(12):781–786. doi:10.5603/GP.2016.0088
   PubMed Web of Science ®Google Scholar
• Moses K, Brandau S. Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. Semin Immunol. 2016;28(2):187–196. doi:10.1016/j.smim.2016.03.018
   PubMed Web of Science ®Google Scholar
• Donskov F. Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol. 2013;23(3):200–207. doi:10.1016/j.semcancer.2013.02.001
   PubMed Web of Science ®Google Scholar
• Burgess B, Levine B, Taylor R, Kelly M. Preoperative circulating lymphocyte and monocyte counts correlate with patient outcomes in type I and type II endometrial cancer. Reprod Sci. 2020;27(1):194–203. doi:10.1007/s43032-019-00009-4
   PubMed Web of Science ®Google Scholar
• Aoyama T, Takano M, Miyamoto M, et al. Pretreatment neutrophil-to-lymphocyte ratio was a predictor of lymph node metastasis in endometrial cancer patients. Oncology. 2019;96(5):259–267. doi:10.1159/000497184
   PubMed Web of Science ®Google Scholar
• Yılmaz E, Coşkun EI, Şahin N, et al. The significance of MPV and N/L value in diagnosıs of endometrial cancer. Turk J Gynecol Oncol. 2016;19:33–36.
   Google Scholar
• Voutsadakis IA. Thrombocytosis as a prognostic marker in gastrointestinal cancers. World J Gastrointest Oncol. 2014;6(2):34–40. doi:10.4251/wjgo.v6.i2.34
   PubMed Web of Science ®Google Scholar
• Sun H, Yin CQ, Liu Q, Wang F, Yuan CH. Clinical significance of routine blood test-associated inflammatory index in breast cancer patients. Med Sci Monitor. 2017;23:5090–5095. doi:10.12659/MSM.906709
   PubMed Web of Science ®Google Scholar
• Pyo JS, Sohn JH, Kang G. Diagnostic and prognostic roles of the mean platelet volume in malignant tumors: a systematic review and meta-analysis. Platelets. 2016;27(8):722–728. doi:10.3109/09537104.2016.1169265
   PubMed Web of Science ®Google Scholar
• Song J, Lai X, Zhang Y, Zheng X, Su J. Preoperative platelet morphology parameters as prognostic predictors for endometrial malignant carcinoma stage and progesterone receptor. Medicine. 2019;98(47):e17818. doi:10.1097/MD.0000000000017818
   PubMed Web of Science ®Google Scholar
• Lei H, Xu S, Mao X, et al. Systemic immune-inflammatory index as a predictor of lymph node metastasis in endometrial cancer. J Inflamm Res. 2021;14:7131–7142. doi:10.2147/JIR.S345790
   PubMed Web of Science ®Google Scholar
• Matsubara S, Mabuchi S, Takeda Y, Kawahara N, KobayashI H, Robinson J. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer. PLoS One. 2021;16(5):e0248871. doi:10.1371/journal.pone.0248871
   PubMed Web of Science ®Google Scholar
• Huang Y, Chen Y, Zhu Y, et al. Postoperative Systemic Immune-Inflammation Index (SII): a superior prognostic factor of endometrial cancer. Front Surg. 2021;8:704235. doi:10.3389/fsurg.2021.704235
   PubMed Web of Science ®Google Scholar
• Cavaliere AF, Perelli F, Zaami S, et al. Towards personalized medicine: non-coding RNAs and endometrial cancer. Healthcare. 2021;9(8):965. doi:10.3390/healthcare9080965
   Web of Science ®Google Scholar
• Niderla-Bielińska J, Jankowska-Steifer E, Włodarski P. Non-coding RNAs and human diseases: current status and future perspectives. Int J Mol Sci. 2023;24(14):11679. doi:10.3390/ijms241411679
   PubMed Web of Science ®Google Scholar
• Piergentili R, Basile G, Nocella C, et al. Using ncRNAs as tools in cancer diagnosis and treatment-the way towards personalized medicine to improve patients’ health. Int J Mol Sci. 2022;23(16):9353. doi:10.3390/ijms23169353
   PubMed Web of Science ®Google Scholar
• Piergentili R, Gullo G, Basile G, et al. Circulating miRNAs as a tool for early diagnosis of endometrial cancer-implications for the fertility-sparing process: clinical, biological, and legal aspects. Int J Mol Sci. 2023;24(14):11356. doi:10.3390/ijms241411356
   PubMed Web of Science ®Google Scholar